Which medication requires complete blood count monitoring due to the increased risk of aplastic anemia?

Question

Quizplus · Accepted Answer

Carbamazepine (Tegretol) is known to increase the risk of aplastic anemia and requires routine monitoring of complete blood counts. Aplastic anemia is a rare but serious condition where the bone marrow is unable to produce enough red blood cells, white blood cells, and platelets. This can lead to severe infections, bleeding, and fatigue. Monitoring blood counts allows for early detection and management of this serious adverse effect. Olanzapine (Zyprexa), aripiprazole (Abilify), and duloxetine (Cymbalta) do not have a known association with aplastic anemia and do not require routine blood count monitoring.

Which Medication Requires Complete Blood Count Monitoring Due to the Increased